Blog
RSS FeedPosted by Michael Wonder on 07 Nov 2018
Update of the Cost Resource Manual
5 November 2018 - PHARMAC recently updated the Cost Resource Manual – the online list of standard costs and prices ...
Posted by Michael Wonder on 06 Nov 2018
Kaitaia mum fights PHARMAC for chance to live
6 November 2018 - Kaitaia mother of three Donna MacMillan knows she is dying, but she's not going without a ...
Posted by Michael Wonder on 05 Nov 2018
Two terminal cancer patients: she gets treatment funded, he doesn't
6 November 2018 - Pamela Jones and Baden Ngan Kee were both told they were going to die after being ...
Posted by Michael Wonder on 05 Nov 2018
RFP - supply of etanercept
5 November 2018 - PHARMAC invites proposals for the supply of etanercept in New Zealand. ...
Posted by Michael Wonder on 31 Oct 2018
Cancer patients call for vitamin C infusion to be affordable
1 November 2018 - Cancer patients are forking out hundreds of dollars for vitamin C infusions they say are providing ...
Posted by Michael Wonder on 31 Oct 2018
New Zealand Pharmaceutical Schedule - 1 November 2018 update
31 October 2018 - The November 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Oct 2018
Proposal to change how discarded medicines are reimbursed
30 October 2018 - PHARMAC is seeking feedback on a proposal to change how the agency reimburses discarded medicines in ...
Posted by Michael Wonder on 28 Oct 2018
Update on proposal to move to one funded brand of lamotrigine (Logem)
26 October 2018 - PHARMAC would like to thank everyone who provided feedback on a proposal to move to one ...
Posted by Michael Wonder on 28 Oct 2018
Calls for PHARMAC review after funds made available to offset wage settlements
24 October 2018 - A request that the government's drug-buying agency be reviewed has opposition support with claims money is ...
Posted by Michael Wonder on 25 Oct 2018
Review PHARMAC model, urge breast cancer petitioners
25 October 2018 - A group of women battling terminal cancer tell the Herald what they would do with extra time. ...
Posted by Michael Wonder on 23 Oct 2018
NZ patients with ALK positive non-small-cell lung cancer score a minor win
23 October 2018 - PTAC has recommended that alectinib hydrochloride be funded for the first-line treatment of ALK positive, locally ...
Posted by Michael Wonder on 22 Oct 2018
Lung cancer survivor wants PHARMAC to fund drugs she received in trial
22 October 2018 - Lung cancer patient Marjolein Baas takes the drug ceritinib, one of six lung cancer treatment drugs the ...
Posted by Michael Wonder on 18 Oct 2018
Northland mum Alethea Nathan with lung cancer pleads for publicly-funded medicine
19 October 2018 - Alethea Nathan has lung cancer, she is relying on her Life Insurance payout to cover the high ...
Posted by Michael Wonder on 17 Oct 2018
Further hepatitis C drug delay 'cruel'
18 October 2018 - PHARMAC's decision to extend consultation on introducing new hepatitis C drugs is cruel and devastating for ...
Posted by Michael Wonder on 16 Oct 2018
Drug companies need to make costs more reasonable
16 October 2018 - Hundreds of women and their families marched on Parliament today to urge the funding of two ...